Related Experiment Video
Updated: May 16, 2026

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Severe acute fibrinous and organizing pneumonia causing acute respiratory distress syndrome and shock
Vimala Rapaka1, Muhammad Azam Hussain, Masooma Niazi
1*Division of Pulmonary Medicine and Critical Care Medicine †Department of Medicine ‡Department of Pathology §Division of Pulmonary and Critical Care Medicine, Albert Einstein College of Medicine, Bronx Lebanon Hospital Center, Bronx, NY.
Abstract:
Acute fibrinous and organizing pneumonia (AFOP) is a newly recognized form of diffuse lung injury. The histologic pattern is described as a variant of cryptogenic organizing pneumonia. AFOP is a very rare finding in a human immunodeficiency virus-infected patient. We present a unique case of a 38-year-old human immunodeficiency virus-infected patient admitted with acute respiratory distress syndrome and shock. Flexible bronchoscopy with transbronchial biopsy was consistent with AFOP. He had clinical and radiologic improvement with a course of systemic corticosteroids. This case illustrates that interstitial lung diseases, specifically AFOP, should be included in the differential diagnosis of diffuse lung diseases in patients with respiratory failure with or without shock. Flexible bronchoscopy aids in establishing the diagnosis.
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-IV
Acute Respiratory Failure-III